logo
15:50 Mar 04

Rubicon Research Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
763.40
-10.00 (-1.29%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Rubicon Research Ltd. Financials

Rubicon Research Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
763.40
-10.00 (-1.29%)
15:50 Mar 04
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

24/100
Expensive Valuation

Technical

28/100
Technically Bearish

Strength

14

Weakness

2

Opportunity

0

Threats

0

24.83 %

ROE %

9.25 %

ROA %

12.52

EPS

35.10

BVPS

10.46 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
393.52 853.89 1284.27 1598.19
Operating Expenses +
375.03 699.3 1028.33 1251.49
Raw Material
162.46 332.1 532.62 644.73
Increase Decrease in Cost
-49.24 -53.01 -157.22 -146.4
Other Manufacturing Expense
0 0 0 0
Employee Cost
97.12 125.34 211.05 244.47
Miscellaneous Expenses
187.59 463.23 599.92 508.69
Operating Profit
18.49 154.59 255.94 346.7
Other Income
25.48 18.5 11.95 12.56
Depreciation
36.06 38.97 36.59 42.65
Interest
18.96 31.26 36.78 43.66
Profit before tax and exceptio..
-11.05 102.86 194.52 272.95
Exceptional Items
0 0 0 0
PBT
-11.05 102.86 194.52 272.95
Provision for Taxation
5.84 11.84 60.16 66.72
Net Profit
-16.89 91.01 134.36 206.19
NET Profit after MI
-16.89 91.01 134.36 206.19
EPS
-1.11 5.98 8.82 13.11
Operating Profit Margin (%)
4.7 18.1 19.93 21.69
Net Profit Margin (%)
-4.29 10.66 10.46 12.9

Rubicon Research Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: